Robert Haynes To Lead Licensing As VR Laboratories' Senior Vice President Product Int. Page 1 of 3
This was printed from Orlando Business Journal Orlando Press Releases Robert Haynes To Lead Licensing As VR Laboratories' Senior Vice President Product Introduction And Licensing Newly appointed SVP brings more than 25 years of experience in pharmaceutical and biotechnology industry leadership to company
BONITA SPRINGS, Fla., Nov. 14, 2012 /PRNewswire-iReach/ -- VR Laboratories LLC today announced the appointment of Robert Haynes as Senior Vice
President, Product Introduction and Licensing. Haynes brings more than 25
years of management and executive experience in pharmaceutical and biotechnology product development, partnering, and global commercialization.
Most recently, Haynes led the Alliance Management and New Product Planning
departments at Human Genome Sciences (HGS). At HGS Haynes also led the development and global commercialization of the company's lead product -
Benlysta® - taking it from discovery through clinical development and
successful commercialization around the world as the first new therapy approved for lupus in over 50 years. In addition to Benlysta Mr. Haynes has
held leadership roles for numerous successful brands including Strattera®,
Evista®, Axid®, Prozac®, and Ceclor®.
http://www.bizjournals.com/orlando/prnewswire/press_releases/Florida/2012/11/14/CG1. 11/15/2012
Robert Haynes To Lead Licensing As VR Laboratories' Senior Vice President Product Int. Page 2 of 3
"Robert brings extensive experience in the pharmaceutical and biotechnology industries to VR and we look forward to his leadership in advancing our
extensive pipeline internally and with partners across the globe," says Jeff
Kottkamp, CEO of VR Laboratories. "As an innovative natural products company, we will benefit from his experience, developing, launching,
commercializing, and partnering assets in all stages across many different
Haynes' background includes a wide variety of commercial management positions in both the pharmaceutical and biotechnology industries. This includes
business development and licensing, strategic marketing, new product
development, global brand and portfolio management, market research, and sales. He began his career with Eli Lilly and company in 1988 following
receiving his Masters of Business Administration degree from the Owen
Graduate School of Management at Vanderbilt University. In addition, he holds a Bachelors degree in Biological Science from DePauw University.
"I look forward to continuing to develop and commercialize innovative
medicines in the rapidly growing natural product industry," says Haynes. "VR Laboratories has great momentum as it looks to grow its business and expand
its global presence. I'm excited to be joining VR's talented team and look
forward to working with them to capitalize on their industry leading technology
to build a successful fully integrated business."
About VR Laboratories
VR Laboratories is an innovative natural products company formed by industry
professionals in 2010 to be the leading global formulator and producer of natural products. VR Laboratories utilizes industry-changing proprietary
technology to create, produce and market "First in Class" condition specific
botanical based consumer health and wellness products, FDA-approved botanical pharmaceuticals and medicines and proprietary ingredients for
medicinal and functional foods and beverages. The company utilizes a
proprietary technology platform, which has fully developed more than 1,000
medicinal and functional ingredients. VR Laboratories is headquartered in Bonita Springs, Florida.
SOURCE VR Laboratories www.vr-laboratories.com
http://www.bizjournals.com/orlando/prnewswire/press_releases/Florida/2012/11/14/CG1. 11/15/2012
Robert Haynes To Lead Licensing As VR Laboratories' Senior Vice President Product Int. Page 3 of 3
Key Words: VR Laboratories, Robert Haynes, Jeff Kottkamp, Wellness,
Media Contact: Jeff Kottkamp, CEO VR Laboratories, 239-597-9878,
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
The information on this page is provided by PR Newswire. All rights
reserved. Reproduction or redistribution of this content without prior written consent from PR Newswire is strictly prohibited. Orlando
Business Journal is not responsible for this content. Learn more
http://www.bizjournals.com/orlando/prnewswire/press_releases/Florida/2012/11/14/CG1. 11/15/2012
United States Court of Appeals for the Federal Circuit IN RE CIPROFLOXACIN HYDROCHLORIDE ANTITRUST LITIGATION --------------------------------------------------------------------------- ARKANSAS CARPENTERS HEALTH AND WELFARE FUND, PAPER, A.F. OF L. - A.G.C. BUILDING TRADES WELFARE PLAN, MARK ASTON, BOARD OF TRUSTEES OF THE UNITED FOOD & COMMERCIAL WORKERS OF ARIZONA HEALTH AND WELFARE
MATERIAL SAFETY DATA SHEET Permount Solution Date of Issue: October 1997 STATEMENT OF HAZARDOUS NATURE Hazardous according to criteria of Worksafe Australia COMPANY DETAILS Company: ProSciTech Address: PO Box 111, Thuringowa Central Qld. 4817 Australia Street Address: 37 Framara Drive, Kelso, Qld, 4815. Australia Telephone Number: Fax Number: IDENTIFICATION SECTIO
Robert Haynes To Lead Licensing As VR Laboratories' Senior Vice President Product Int. Page 2 of 3
"Robert brings extensive experience in the pharmaceutical and biotechnology industries to VR and we look forward to his leadership in advancing our
extensive pipeline internally and with partners across the globe," says Jeff
Kottkamp, CEO of VR Laboratories. "As an innovative natural products company, we will benefit from his experience, developing, launching,
commercializing, and partnering assets in all stages across many different
Haynes' background includes a wide variety of commercial management positions in both the pharmaceutical and biotechnology industries. This includes
business development and licensing, strategic marketing, new product
development, global brand and portfolio management, market research, and sales. He began his career with Eli Lilly and company in 1988 following
receiving his Masters of Business Administration degree from the Owen
Graduate School of Management at Vanderbilt University. In addition, he holds a Bachelors degree in Biological Science from DePauw University.
"I look forward to continuing to develop and commercialize innovative
medicines in the rapidly growing natural product industry," says Haynes. "VR Laboratories has great momentum as it looks to grow its business and expand
its global presence. I'm excited to be joining VR's talented team and look
forward to working with them to capitalize on their industry leading technology
to build a successful fully integrated business."
About VR Laboratories